Herzuma 150 mg, poudre pour solution à diluer pour perfusion - Swissmedic Key 67892002 Registration Holder iQone Healthcare Switzerland SA Name Herzuma 150 mg, poudre pour solution à diluer pour perfusion Date of registration 13.07.2021 Introduction of Sequence 13.07.2021 ATC-Classification (L01FD01) Revision date WHO WHO-DDD Valid until 13.07.2026 Index Therapeuticus (BSV) 07.16.10. Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 456.84 Limitation Yes Limitation text
Deductible 10 % Consumer price 513.25 Feedback FB GTIN 7680678920027 Medication Code Biotechnologika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: trastuzumabum 150 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form poudre pour solution à diluer pour perfusion Excipiens Active Agent Dose Trastuzumab 150 mg
BAG: Active Agent Dose Trastuzumab 150 mg
Inactive agents Histidin Hydrochloride Monohydrate Histidine Polysorbatum 20 Trehalosum Dihydricum
Source Data was imported : 06.07.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
